Sandu Pharmaceuticals Q2 Results

  • BSE: 524703
  • NSE: -
  • ISIN: INE751D01014
  • Sector: Biotechnology & Drugs
BSE
57.820.02 (0.03%)
Volume1.30 K
Updated: Tue 26 Nov, 2024 | 15:21:03
NSE
This stock is not traded on NSE
Today: 57.00
59.15
52-Wk: 54.00
85.00

Technical Trends

Long Term
Considers price movement over the last 6 months

Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Sandu Pharmaceuticals Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 23Jun 23QoQ Comp
    Total Revenue 16.6117.66-%
    Selling/ General/ Admin Expenses Total 2.552.52-%
    Depreciation/ Amortization 0.130.12-%
    Other Operating Expenses Total 4.945.33-%
    Total Operating Expense 15.9117.42-%
    Operating Income 0.690.23-%
    Net Income Before Taxes 0.770.21-%
    Net Income 0.550.11-%
    Diluted Normalized EPS 0.570.11-%

    EQUITY QUICK LINKS

    FROM MARKETS

    RELATED LINKS

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market

        HomeMarketsPremiumInstant LoanMint Shorts

        Wait for it…

        Log in to our website to save your bookmarks. It'll just take a moment.